Cerebras IPO 2026: $5.55B Raise, $56.4B Valuation

Deal snapshot as Cerebras heads to Nasdaq

Cerebras Systems, the Sunnyvale, California-based AI chipmaker, is set for its Nasdaq debut in what is being described as the largest market debut of the year. The company’s shares are expected to start trading on the Nasdaq Global Select Market on May 14 under the ticker CBRS, with the offering scheduled to close on May 15, subject to customary closing conditions. In premarket activity on Thursday, Cerebras shares were indicated at $185.00, according to Benzinga Pro data.

Investor attention has been heightened by rapid changes in the terms of the offering, including multiple upward revisions to the expected pricing range during bookbuilding. The IPO comes at a time when broader US equity signals are mixed, with the Nasdaq down 0.01% and the Dow Jones up 0.90%, a backdrop that can shape sentiment around first-day trading.

Final pricing lands well above the revised range

Cerebras ultimately priced its IPO at $185 a share, which was far above its previously announced revised range of $150 to $160 per share. That $150 to $160 range itself had been raised from an initial $115 to $125 per share disclosed in an amended S-1 dated May 4. Reports tied the step-up in pricing to demand that oversubscribed the deal by more than 20 times.

By gross proceeds, Cerebras raised about $1.55 billion, according to Dow Jones Market Data. The deal size was also increased through the process, including an increase in shares to be offered to 30 million, up from 28 million. In addition, the company has an option for underwriters to purchase up to 4.5 million shares, a mechanism that can be used when demand remains strong after pricing.

How the offer evolved during bookbuilding

The pricing journey was closely followed by market participants because it provides a read-through on appetite for pure-play AI hardware listings. The deal began with a $115 to $125 price range when Cerebras filed its amended S-1 on May 4. Bloomberg first reported a move to lift the range to $125 to $135. Reuters later reported Cerebras was considering a further increase to $150 to $160 after investor orders surpassed $10 billion against $1.5 billion of shares on offer.

Morgan Stanley, Citigroup, Barclays, and UBS were named as running the offering. CNBC also reported that Nasdaq expected the IPO to proceed on May 14, aligning with the company’s listing plans. The IPO pricing was widely expected to occur ahead of trading, with May 13 cited as the pricing date and May 14 as the debut.

What Cerebras builds, and why inference is central

Cerebras Systems develops ultra-high-performance AI infrastructure designed to accelerate AI workloads. Its flagship Wafer-Scale Engine 3 (WSE-3) is described by the company as the world’s largest commercially available AI processor, positioned around faster inference and improved power efficiency versus traditional GPU-based systems.

Cerebras says WSE-3 can deliver up to 15x faster inference on leading open-source AI models while consuming less power per unit of compute. The company serves enterprises, research institutions, and governments through cloud and on-premises deployments. Cerebras has also positioned its CS-3 AI supercomputer, built around its Wafer-Scale Engine, as a product tailored for inference workloads.

Financial performance disclosed for 2025

Cerebras reported 2025 revenue of $110 million, representing 76% year-on-year growth. The company also reported net income of $138 million, implying a 47% net margin. These figures have been central to how investors frame valuation, particularly given how quickly the deal’s implied market capitalisation expanded as the price moved higher.

Alongside financial results, market commentary pointed to contracted business as part of the equity story. The bull case described in reporting cited OpenAI and Amazon Web Services relationships, and a remaining performance obligation balance of $14.6 billion.

Valuation markers: from private rounds to IPO pricing

At the IPO price of $185 a share, Cerebras was described as targeting a market valuation of about $16.4 billion. MarketWatch also cited that this level would be more than 100 times the company’s 2025 revenue of $110 million. The valuation compares with a $13 billion valuation following a $1 billion Series H funding round in February, according to commentary cited in the reporting.

Morningstar senior equity analyst Brian Colello highlighted how quickly valuation expectations changed, referencing a valuation of $1 billion in October and pointing to large deals with OpenAI and Amazon Web Services as supporting that shift. But he also cautioned on the breadth and scale of competition.

Competition and spend: the context investors are weighing

Cerebras competes in a market that includes established chip designers and cloud platforms, with rivals cited as Nvidia, AMD, Google, AWS, Microsoft, Meta, Broadcom, Marvell, and MediaTek. The competitive issue is not only product capability, but also the scale of research spending. One reference point cited was Nvidia spending more than $18 billion in its most recent financial year.

This matters because Cerebras is being marketed as an inference-focused alternative to general-purpose GPUs, at a time when the industry narrative is shifting toward deployment workloads. The company’s positioning is that inference demand is rising as more models move from training into real-world use.

Market backdrop and what it can mean for debut trading

The IPO is landing amid mixed index performance, with the Nasdaq marginally lower and the Dow sharply higher on the day cited. That kind of split can influence how investors approach a high-profile new listing, especially one priced aggressively.

Separate from the index moves, the premarket indication at $185.00 underscored how closely the market is tracking the final IPO price and the first trade. Liquidity dynamics can also be shaped by allocations, particularly after a heavily oversubscribed book.

Key figures at a glance

Why this IPO is being treated as a sentiment test

Multiple sources framed Cerebras as a test of how much further the AI-infrastructure trade can extend, because the company is being priced on future expectations. That framing reflects the combination of rapid IPO repricing, very high implied multiples referenced in reporting, and a competitive landscape where incumbents invest heavily.

At the same time, the company is entering public markets with a clear product narrative around inference acceleration and power efficiency, supported by stated performance claims for WSE-3 and a customer base spanning enterprise, research, and government deployments.

Conclusion

Cerebras’ Nasdaq debut on May 14 follows an IPO that repriced sharply higher during bookbuilding, culminating in a $185 issue price and about $1.55 billion in gross proceeds. The offering is scheduled to close on May 15, and trading under ticker CBRS will provide the market’s first real-time test of demand for a high-valuation, inference-focused AI hardware listing. Investors are likely to watch early trading alongside the company’s ability to sustain growth and compete against far larger rivals with deep R&D budgets.